We describe 4 patients, aged 3 months to 23 years, with end-stage renal dis
ease and severe, symptomatic hypothyroidism. All 4 had primary hyperoxaluri
a type 1 (PH1) with diffuse tissue (kidneys, skeleton, eyes, heart) calcium
-oxalate deposition, a condition known as oxalosis. The hypothyroidism resp
onded to thyroid hormone replacement therapy. Clinical hypothyrodism within
the framework of PH1/oxalosis was probably caused by thyroid tissue damage
from an abundance of calcium oxalate. Were recommend that thyroid function
be monitored In patients with PH1 and oxalosis.